The Importance of Prompt Blood Pressure Control

No abstract is available for this paper.

• Publication year

  2008

• Venue

  The Journal of Clinical Hypertension

• Publication date

  2008-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1524-6175.2007.08027.xPMID 18174779PMCID PMC8110160
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rationale for Fixed-Dose Combinations in the Treatment of Hypertension

  2012cited by this paper
• Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis

  2008cited by this paper
• Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2008cited by this paper
• Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004

  2008cited by this paper
• 2007 Guidelines for the management of arterial hypertension

  2007cited by this paper
• Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention

  2007cited by this paper
• Prevalence of actions to control high blood pressure--20 states, 2005.

  2007cited by this paper
• Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents.

  2007cited by this paper
• Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004

  2007cited by this paper
• Fixed-dose combinations improve medication compliance: a meta-analysis.

  2007cited by this paper
• Risk of diabetes in a real-world setting among patients initiating antihypertensive therapy with valsartan or amlodipine

  2007cited by this paper
• Hypertension Management: Results of a New National Survey for the Hypertension Education Foundation: Harris Interactive

  2007cited by this paper
• Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2007cited by this paper
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cited by this paper
• Exceptional early blood pressure control rates: The ACCOMPLISH trial

  2007cited by this paper
• Guidelines for management of arterial hypertension

  2007cited by this paper
• Abstract 4025: Prevalence, Awareness, Treatment, and Control of Hypertension in the United States 1999–2004

  2006cited by this paper
• Prevalence, Awareness, Treatment, and Control of Hypertension: United States National Health and Nutrition Examination Survey 2001–2002

  2006cited by this paper
• Initiation of hypertension treatment with a fixed‐dose combination or its monocomponents – does it really matter?

  2006cited by this paper
• Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control Goals

  2006cited by this paper
• American Heart Association Statistics Committee and Stroke Statistics Subcommittee : Heart disease and stroke statistical-2006 update : A report from the American Heart Association Statistics Committee and Stroke statistics subcommittee

  2006cited by this paper
• Incremental Risk‐Factor Reduction Improves Overall Cardiovascular Benefit: Is It Time to Abandon the Silos?

  2006cited by this paper
• Overcoming barriers to effective blood pressure control in patients with hypertension

  2006cited by this paper
• The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapy

  2006cited by this paper
• Global burden of hypertension: analysis of worldwide data.

  2005cited by this paper
• Blood Pressure Reduction and Cardiovascular Prevention: An Update Including the 2003–2004 Secondary Prevention Trials

  2005cited by this paper
• Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri

  2005cited by this paper
• Efficacy of a Fixed-Dose Combination of Trandolapril-Verapamil in Patients with Stage 2 Hypertension Inadequately Controlled by Monotherapy

  2005cited by this paper
• Blood Pressure Control and Factors Predicting Control in a Treatment‐Compliant Male Veteran Population

  2004cited by this paper
• Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension.

  2004cited by this paper
• The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization

  2004cited by this paper
• Hypertension Treatment and Control in Five European Countries, Canada, and the United States

  2004cited by this paper
• Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial

  2004cited by this paper
• Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

  2004cited by this paper
• Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.

  2004cited by this paper
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

  2003cited by this paper
• Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

  2003cited by this paper
• Improving Patient Compliance: A Major Goal in the Management of Hypertension

  2003cited by this paper
• The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

  2003cited by this paper
• Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

  2003cited by this paper
• Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy.

  2003cited by this paper
• Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

  2002cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2002cited by this paper
• Is fixed combination therapy appropriate for initial hypertension treatment?

  2002cited by this paper
• Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

  2000cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper

• Prunus yedoensis Bark Downregulates the Expression of Cell Adhesion Molecules in Human Endothelial Cell Lines and Relaxes Blood Vessels in Rat Aortic Rings

  2024cites this paper
• Can the effectiveness of hypertension management be improved?

  2013cites this paper
• How can resistant hypertension be identified and prevented?

  2013cites this paper
• Current challenges in the clinical management of hypertension

  2012cites this paper
• Are there new threshold and goals in the treatment of arterial hypertension?

  2012cites this paper
• Using impedance cardiography with postural change to stratify patients with hypertension

  2011cites this paper
• Time to Achieve Blood Pressure Goal with a Combination Versus a Conventional Monotherapy Approach in Hypertensive Patients with Metabolic Syndrome

  2010influential citation
• The Clock Is Ticking: The Case for Achieving More Rapid Control of Hypertension

  2010cites this paper
• The Expectant Model of Hypertension Management: Setting Expectations to Achieve Blood Pressure Control—Applying a Business Principle to Hypertension Management

  2009cites this paper